Lv1
10 积分 2023-09-09 加入
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status
2个月前
已完结
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2个月前
已完结
Erythroderma and a Pulmonary Nodule
2个月前
已完结
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
5个月前
已完结
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
5个月前
已完结
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapy
5个月前
已完结
Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer
5个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
5个月前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
9个月前
已完结
A phase 2, open-label study of neoadjuvant chemotherapy plus tislelizumab followed by radiotherapy-based, bladder-preserving treatment for high risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02)
11个月前
已完结
皖公网安备34019202002308
